Effects of caffeine on striatal neurotransmission: Focus on cannabinoid CB1 receptors

Molecular Nutrition and Food Research

Volumn 54, Issue 4, 2010, Pages 525-531

  Rossi, Silvia ^a,b   de Chiara, Valentina ^a,b   Musella, Alessandra ^a,b   Mataluni, Giorgia ^a,b   Sacchetti, Lucia ^a   Siracusano, Alberto ^a   Bernardi, Giorgio ^a,b   Usiello, Alessandro ^c,d   Centonze, Diego ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^d UNIVERSITY OF MOLISE   (Italy)

Author keywords

Adenosine; IPSC; Psychostimulant; Reward; Stress

Indexed keywords

ADENOSINE A2A RECEPTOR; CAFFEINE; CANNABINOID 1 RECEPTOR; CENTRAL STIMULANT AGENT;

ANIMAL; BEHAVIOR; CORPUS STRIATUM; DRUG EFFECT; HUMAN; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; REVIEW; SYNAPTIC TRANSMISSION;

ANIMALS; BEHAVIOR; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; HUMANS; PSYCHOMOTOR PERFORMANCE; RECEPTOR, ADENOSINE A2A; RECEPTOR, CANNABINOID, CB1; SYNAPTIC TRANSMISSION;

EID: 77951067861     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900237     Document Type: Review

References (54)

1. Fisone, G., Borgkvist, A., Usiello, A., Caffeine as a psychomotor stimulant: mechanism of action. Cell. Mol. Life Sci. 2004,61,857-872.
2. Borgkvist, A., Fisone, G., Psychoactive drugs and regulation of the cAMP/PKA/DARPP-32 cascade in striatal medium spiny neurons. Neurosci. Biobehav. Rev. 2007, 31, 79-88.
3. Daly, J. W., Fredholm, B. B., Caffeine an atypical drug of dependence. Drug Alcohol Depend. 1998, 51, 199-206.
4. Strain, E. C., Mumford, G. K., Silverman, K., Griffiths, R. R., Caffeine dependence syndrome. Evidence from case histories and experimental evaluations. J. Am. Med. Assoc. 1994,272,1043-1048.
5. Ogawa, N., Ueki, H., Clinical importance of caffeine dependence and abuse. Psychiatry Clin. Neurosci. 2007, 61, 263-268.
6. Nehlig, A., Are we dependent upon coffee and caffeine? A review on human and animal data. Neurosci. Biobehav. Rev. 1999, 23, 563-576.
7. Miller, K. E., Energy drinks, race, and problem behaviors among college students. J. Adolesc. Health 2008, 43, 490-497.
8. Reissig, C. J., Strain, E. C., Griffiths, R., Caffeinated energy drinks - a growing problem. Drug Alcohol Depend. 2009, 99, 1-10.
9. Vanderschuren, L. J., Di Ciano, P., Everitt, B. J., Involvement of the dorsal striatum in cue-controlled cocaine seeking. J. Neurosci. 2005, 25, 8665-8670.
10. Balleine, B. W., Delgado, M. R., Hikosaka, O., The role of the dorsal striatum in reward and decision-making. J. Neurosci. 2007,27,8161-8165.
11. Fisone, G., Hakansson, K., Borgkvist, A., Santini, E., Signaling in the basal ganglia: postsynaptic and presynaptic mechanisms. Physiol. Behav. 2007, 92, 8-14.
12. Di Ciano, P., Robbins, T. W., Everitt, B. J., Differential effects of nucleus accumbens core, shell, or dorsal striatal inactivations on the persistence, reacquisition, or reinstatement of responding for a drug-paired conditioned reinforcer. Neuropsychopharmacology 2008, 33, 1413-1425.
13. Amalric, M., Koob, G. F., Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system. Prog. Brain Res. 1993, 99,209-226.
14. Berke, J. D., Hyman, S. E., Addiction, dopamine, and the molecular mechanisms of memory. Neuron 2000, 25, 515-532.
15. Rossi, S., De Chiara, V., Musella, A., Mataluni, G. et al., Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects. Neuropharmacology 2009, 56, 590-597.
16. Navarro, M., Carrera, M. R., Fratta, W., Valverde, O. et al., Functional interaction between opioid and cannabinoid receptors in drug self-administration. J. Neurosci. 2001, 21, 5344-5350.
17. Centonze, D., Rossi, S., De Chiara, V., Prosperetti, C. et al., Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors. Eur. J. Neurosci. 2007, 25, 1631-1640.
18. Corbillé, A. G., Valjent, E., Marsicano, G., Ledent, C. et al., Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants. J. Neurosci. 2007, 27, 6937-6947.
19. Bisogno, T., Ligresti, A., Di Marzo, V., The endocannabinoid signalling system: biochemical aspects. Pharmacol. Biochem. Behav. 2005, 81, 224-238.
20. Basavarajappa, B. S., Neuropharmacology of the endocannabinoid signaling system - molecular mechanisms, biological actions and synaptic plasticity. Curr. Neuropharmacol. 2007, 5, 81-97.
21. Ballarín, M., Fredholm, B. B., Ambrosio, S., Mahy, N., Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol. Scand. 1991, 142, 97-103.
22. Klotz, K. N., Hessling, J., Hegler, J., Owman, C. et al., Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch. Pharmacol. 1998,357,1-9.
23. Carter, A. J., O'Connor, W. T., Carter, M. J., Ungerstedt, U., Caffeine enhances acetylcholine release in the hippo- campus in vivo by a selective interaction with adenosine A1 receptors. J. Pharmacol. Exp. Ther. 1995, 273, 637-642.
24. Van Dort, C. J., Baghdoyan, H. A., Lydic, R., Adenosine A(1) and A(2A) receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal. J. Neurosci. 2009,29,871-881.
25. Fredholm, B. B., Battig, K., Holmén, J., Nehlig, A., Zvartau, E. E., Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 1999, 51, 83-133.
26. Howell, L. L., Comparative effects of caffeine and selective phosphodiesterase inhibitors on respiration and behavior in rhesus monkeys. J. Pharmacol. Exp. Ther. 1993, 266, 894-903.
27. Lopez, F., Miller, L. G., Greenblatt, D. J., Kaplan, G. B., Shader, R. I., Interaction of caffeine with the GABAA receptor complex: alterations in receptor function but not ligand binding. Eur. J. Pharmacol. 1989, 172, 453-459.
28. Wang, S. J., Caffeine facilitation of glutamate release from rat cerebral cortex nerve terminals (synaptosomes) through activation protein kinase C pathway: an interaction with presynaptic adenosine A1 receptors. Synapse 2007, 61, 401-411.
29. Calabresi, P., Pisani, A., Mercuri, N. B., Bernardi, G., The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci. 1996, 19,19-24.
30. Ferré, S., Fredholm, B. B., Morelli, M., Popoli, P., Fuxe, K., Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 1997, 20, 482-487.
31. Lindskog, M., Svenningsson, P., Pozzi, L., Kim, Y. et al., Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 2002, 418, 774-778.
32. Bibb, J. A., Snyder, G. L., Nishi, A., Yan, Z. et al., Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 1999, 402, 669-671.
33. Ferré, S., Ciruela, F., Borycz, J., Solinas, M. et al., Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain. Front. Biosci. 2008, 13, 2391-2399.
34. Piomelli, D., The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 2003, 4, 873-884.
35. Rossi, S., De Chiara, V., Musella, A., Kusayanagi, H. et al., Chronic psychoemotional stress impairs cannabinoidreceptor-mediated control of GABA transmission in the striatum. J. Neurosci. 2008, 28, 7284-7292.
36. Beltramo, M., de Fonseca, F. R., Navarro, M., Calignano, A. et al., Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. J. Neurosci. 2000, 20, 3401-3407.
37. Centonze, D., Battista, N., Rossi, S., Mercuri, N. B. et al., A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal GABAergic transmission. Neuropsychopharmacology 2004, 29, 1488-1497.
38. Carriba, P., Ortiz, O., Patkar, K., Justinova, Z. et al., Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology 2007, 32,2249-2259.
39. Tebano, M. T., Martire, A., Chiodi, V., Pepponi, R. et al., Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1receptors in the rodent striatum. J. Neurochem. 2009, 110, 1921-1930.
40. Andersson, M., Usiello, A., Borgkvist, A., Pozzi, L. et al., Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. J. Neurosci. 2005, 25, 8432-8438.
41. Aoyama, S., Kase, H., Borrelli, E., Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist. J. Neurosci. 2000, 20, 5848-5852.
42. Chen, J. F., Moratalla, R., Impagnatiello, F., Grandy, D. K. et al., The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proc. Natl. Acad. Sci. USA 2001, 98, 1970-1975.
43. Davis, J. M., Zhao, Z., Stock, H. S., Mehl, K. A. et al., Central nervous system effects of caffeine and adenosine on fatigue. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284, R399-R404.
44. Nikodijević, O., Jacobson, K. A., Daly, J. W., Locomotor activity in mice during chronic treatment with caffeine and withdrawal. Pharmacol. Biochem. Behav. 1993, 44, 199-216.
45. El Yacoubi, M., Ledent, C., Ménard, J. F., Parmentier, M. et al., The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors. Br. J. Pharmacol. 2000, 129, 1465-1473.
46. Kalda, A., Yu, L., Oztas, E., Chen, J. F., Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease. J. Neurol. Sci. 2006,248,9-15.
47. Bedingfield, J. B., King, D. A., Holloway, F. A., Cocaine and caffeine: conditioned place preference, locomotor activity, and additivity. Pharmacol. Biochem. Behav. 1998, 61, 291-296.
48. Simola, N., Cauli, O., Morelli, M., Sensitization to caffeine and cross-sensitization to amphetamine: influence of individual response to caffeine. Behav. Brain Res. 2006, 172, 72-79.
49. Green, T. A., Schenk, S., Dopaminergic mechanism for caffeine-produced cocaine seeking in rats. Neuropsychopharmacology 2002, 26, 422-430.
50. Celik, E., Uzbay, I. T., Karakas, S., Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30, 50-55.
51. Hnasko, T. S., Sotak, B. N., Palmiter, R. D., Morphine reward in dopamine-deficient mice. Nature 2005, 438, 854-857.
52. Kawachi, I., Willett, W. C., Colditz, G. A., Stampfer, M. J., Speizer, F. E., A prospective study of coffee drinking and suicide in women. Arch. Int. Med. 1996, 156, 521-525.
53. Takeda, E., Terao, J., Nakaya, Y., Miyamoto, K. et al., Stress control and human nutrition. J. Med. Invest. 2004, 51, 139-145.
54. Steptoe, A., Gibson, E. L., Vuononvirta, R., Williams, E. D. et al., The effects of tea on psychophysiological stress responsivity and post-stress recovery: a randomised double-blind trial. Psychopharmacology 2007, 190, 81-89.